Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

LIMB GIRDLE SYNDROMES: MYASTHENIA OR MYOPATHY

Conference paper

Cruz PR. et al, (2016), Journal of neurology, neurosurgery & psychiatry, 87, e1.84 - e1

Clinical features of the myasthenic syndrome arising from mutations in GMPPB.

Journal article

Rodríguez Cruz PM. et al, (2016), J neurol neurosurg psychiatry, 87, 802 - 809

Congenital myasthenic syndrome caused by mutations in DPAGT.

Journal article

Klein A. et al, (2015), Neuromuscul disord, 25, 253 - 256

Collagen Q--a potential target for autoantibodies in myasthenia gravis.

Journal article

Zoltowska Katarzyna M. et al, (2015), J neurol sci, 348, 241 - 244

Collagen Q - A potential target for autoantibodies in myasthenia gravis

Journal article

Zoltowska Katarzyna M. et al, (2015), Journal of the neurological sciences, 348, 241 - 244

Clinical features of congenital myasthenic syndrome due to mutations in DPAGT1.

Journal article

Finlayson S. et al, (2013), J neurol neurosurg psychiatry, 84, 1119 - 1125

Clinical features of congenital myasthenic syndrome due to mutations in DPAGT1

Journal article

Finlayson S. et al, (2013), Journal of neurology, neurosurgery and psychiatry, 84, 1119 - 1125

The search for new antigenic targets in myasthenia gravis.

Journal article

Cossins J. et al, (2012), Ann n y acad sci, 1275, 123 - 128

Load More